Fred Alger Management »

BioCryst Pharmaceuticals shares owned by Fred Alger Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.2M 124k 9.52

More positions owned by Fred Alger Management

NVIDIA Corporation Equity (NVDA)
Microsoft Corporation Equity (MSFT)
Amazon.com Equity (AMZN)
Apple Equity (AAPL)
Alphabet Inc. Class C Equity (GOOG)
Meta Platforms Inc Class A Equity (META)
Nebius Group N.V. Class A Equity (NBIS)
Broadcom Equity (AVGO)
Western Digital Corporation Equity (WDC)
Tesla Equity (TSLA)
AppLovin Corp. Class A Equity (APP)
Qxo Equity (QXO)
Talen Energy Corp Equity (TLN)
Natera Equity (NTRA)
GE Vernova Equity (GEV)

View all positions for Fred Alger Management

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
RA Capital Management
Deerfield Management Company
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
TCG Crossover Management
Henderson Group
Perceptive Advisors
Vestal Point Capital
Two Sigma Investments
Geode Capital Management
Kynam Capital Management
Bank of America Corporation

View all funds holding BioCryst Pharmaceuticals